Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,648.9
28.7 (1.10%)

 

  • STI Straits Times Index
    2,648.9
    28.7 (1.10%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,585.6
    -13.2 (-0.83%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,481.6
    3.7 (0.01%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,361.3
    -53.3 (-1.56%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,945.5
    358.5 (1.59%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,075.8
    -3.3 (-0.07%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,366.2M
  • Value: 1,138.6M
  • Rise: 196
  • Fall: 167
  • Unch: 447

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.176+0.007
IX Biopharma0.285-0.030
Biolidics0.435-0.085
Singapore-eDev0.091-0.011
Hyphens Pharma0.420-0.060
Clearbridge0.186-0.002
QT Vascular0.008-
Medtecs Intl0.645+0.010
Genting Sing0.785+0.010
Singtel2.540+0.020

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS ZEALAND PHARMA A/S SPONSORED ADR
Updated on 14 Jul 2020 (End of trading day)
Last (USD): 34.500 Change: +0.010 High: 34.510 Remarks: -
Change (%): +0.03 Low: 33.840
Open 34.000 Yesterday's Close 34.49
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 12,677 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -2.15632 Trailing EPS (USD) e -2.33236 NAV (USD) b 4.4977
PE a - Trailing PE f - Price / NAV b 7.6706
Dividend (USD) d - Cash In Hand (USD) g 3.6996 Issued & Paid-up Shares c 39,734,100
Dividend Yield (%) d - Price / Cash In Hand g 9.325 Treasury Shares h 64,223
Market Cap (M) 1,370.826 Enterprise Value (M) 1,195.929
Piotroski F Score 0 Exchange Code ZEAL Par Value ( $ ) n.a.
52 Weeks Volatility (%) 69.84 Free Float (%) 93.0
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 23 Jun 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 11 Mar 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS NASDAQ 1,370.826 - - 7.6706 -
Industry Pharmaceuticals: Major NASDAQ 1,697.575 114.250 1786.655 2.9576 0.008
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 130,920.122 40.238 40.238 1.9790 2.248
Local Peer ROYALTY PHARMA PLC NASDAQ 26,418.163 11.249 11.249 - -
Local Peer REPLIGEN CORP NASDAQ 6,529.844 304.979 281.787 6.1040 -
Local Peer GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 NASDAQ 5,024.588 7.181 6.489 0.8261 -
Local Peer REATA PHARMACEUTICALS INC NASDAQ 5,020.609 - - 21.9579 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 4,946.265 - - -29.7381 -
Local Peer NEKTAR THERAPEUTICS NASDAQ 4,198.784 - - 3.2387 -
Local Peer HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS NASDAQ 4,064.489 - - 14.1123 -
Local Peer ALLAKOS INC NASDAQ 3,511.174 - - 7.3448 -
Local Peer OPKO HEALTH INC NASDAQ 2,706.109 - - 1.7474 -
Local Peer TURNING POINT THERAPEUTICS INC NASDAQ 2,564.432 - - 6.7183 -
Local Peer KARUNA THERAPEUTICS INC NASDAQ 2,446.300 - - 6.3550 -
Other Local Peers APELLIS PHARMACEUTICALS INC (NASDAQ), PRINCIPIA BIOPHARMA INC (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), TRICIDA INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), GOSSAMER BIO INC (NASDAQ), PETIQ INC (NASDAQ), ATHENEX INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), GENERATION BIO CO (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), AC IMMUNE SA (NASDAQ), 89BIO INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), BEYONDSPRING INC (NASDAQ), DURECT CORP (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), IMARA INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), MENLO THERAPEUTICS INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), POLYPID LTD (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), VERU INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), IMMUNIC INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), MUSTANG BIO INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), OBSEVA SA (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), GENPREX INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), EVOLUS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), THE FS ALSEC ALPHASECTOR (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), BAUDAX BIO INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), EYENOVIA INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), MANNATECH INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), NOVAN INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), HISTOGEN INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), SPRING BANK PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), PROPHASE LABS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 389,708.553 25.776 22.702 6.3580 2.533
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 215,793.738 30.617 21.622 - -
Global Peer MERCK & CO INC NYSE 197,510.825 20.066 19.465 7.5372 2.905
Global Peer PFIZER INC NYSE 195,696.661 12.027 12.394 3.0103 4.129
Global Peer ABBVIE INC NYSE 174,242.556 22.219 20.765 -23.4985 3.726
Global Peer ELI LILLY AND COMPANY NYSE 156,839.387 33.817 28.345 50.9419 1.575
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 141,672.669 105.684 190.488 - -
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 130,987.124 38.089 137.303 2.6244 2.858
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 118,704.554 20.329 19.756 14.8402 -
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 102,101.648 17.230 21.169 - -
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), WUXI APPTEC (HKEx), HANSOH PHARMA (HKEx), INNOVENT BIO (HKEx), SINOPHARM (HKEx), CANSINOBIO-B (HKEx), JUNSHI BIO (HKEx), SH PHARMA (HKEx), BAIYUNSHAN PH (HKEx), HENLIUS-B (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), CHINARES PHARMA (HKEx), AKESO-B (HKEx), HEPALINK (HKEx), CMS (HKEx), ADC THERAPEUTICS SA (NYSE), TRAD CHI MED (HKEx), CHINAGRANDPHARM (HKEx), OCUMENSION-B (HKEx), INNOCARE-B (HKEx), HYGEIA HEALTH (HKEx), SSY GROUP (HKEx), UNITED LAB (HKEx), ZYMEWORKS INC (NYSE), AMNEAL PHARMACEUTICALS INC (NYSE), CSTONE PHARMA-B (HKEx), CKLIFE SCIENCES (HKEx), TONGRENTANGCM (HKEx), IMMUNOTECH-B (HKEx), HUA MEDICINE-B (HKEx), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), IGBB (Bursa), SHINEWAY PHARM (HKEx), Kimia Farma Tbk. (IDX), FUSEN PHARM (HKEx), TOT BIOPHARM-B (HKEx), AFT PHARMACEUTICALS LTD (ASX), STARPHARMA HOLDINGS LIMITED (ASX), BSTEAD (Bursa), PYC THERAPEUTICS LIMITED (ASX), LANNETT CO INC (NYSE), CH BIOTECH SER (HKEx), DAWNRAYS PHARMA (HKEx), PHARMA (Bursa), IX Biopharma (SGX), BIOMX INC (NYSE American), ZHONGZHIPHARM (HKEx), Merck Tbk. (IDX), RECCE PHARMACEUTICALS LTD (ASX), Hyphens Pharma (SGX), KOTRA (Bursa), PAK FAH YEOW (HKEx), NEW RAY MEDIC (HKEx), RACE ONCOLOGY LTD (ASX), CHARMACY PHAR (HKEx), NC HEALTHCARE (HKEx), Phapros Tbk. (IDX), ONCOSIL MEDICAL LIMITED (ASX), PALLA PHARMA LTD (ASX), IP (SET), NOVA (Bursa), NEP INTERLONG (HKEx), WAI YUEN TONG (HKEx), NOXOPHARM LTD (ASX), TBG DIAGNOSTICS LTD (ASX), ANNOVIS BIO INC (NYSE American), PURAPHARM (HKEx), SANAI HEALTH GP (HKEx), INVION LTD (ASX), AGEX THERAPEUTICS INC (NYSE American), JCT (SET), EXTRAWELL PHAR (HKEx), BIOHLDG (Bursa), MEDLAB CLINICAL LIMITED (ASX), IMMURON LIMITED (ASX), PHARMAXIS (ASX), TIMBER PHARMACEUTICALS INC (NYSE American), SINOLIFE UTD (HKEx), EXOPHARM LTD (ASX), ACRUX (ASX), PASHUN INT'L (HKEx), TALI DIGITAL LIMITED (ASX), SUNZEN (Bursa), CELLMID LIMITED (ASX), CRESO PHARMA LTD (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), SUDA PHARMACEUTICALS LTD (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX), FIJI KAVA LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --2.460
-6.66 %
10 Days --0.260
-0.75 %
20 Days --6.280
-15.40 %
Medium Term Return 3 Months -+2.885
+9.13 %
6 Months --1.580
-4.38 %
1 Year -+11.640
+50.92 %
Long Term Return 2 Years -+18.980
+122.29 %
Annualised Return Annualised --
+49.10 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 18.750 - 44.600 Change From 1 Year Low +15.750 % Change From 1 Year Low (%) +84.00
Change From 1 Year High -10.100 % Change From 1 Year High (%) -22.65
2 Years Range 11.510 - 44.600 Change From 2 Years Low +22.990 % Change From 2 Years Low (%) +199.74
Change From 2 Years High -10.100 % Change From 2 Years High (%) -22.65
5 Years Range 11.510 - 44.600 Change From 5 Years Low +22.990 % Change From 5 Years Low (%) +199.74
Change From 5 Years High -10.100 % Change From 5 Years High (%) -22.65
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Zealand Pharma A/S is a biotechnology company that engages in the discovery, design and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Soborg, Denmark.

Historical Price Data

Date Open High Low Close Volume VWAP
14 Jul 2020 34.000 34.510 33.840 34.500 12,677 -
13 Jul 2020 35.290 35.450 34.490 34.490 4,652 -
10 Jul 2020 35.640 35.640 35.360 35.480 841 -
09 Jul 2020 36.500 36.600 36.340 36.600 4,603 -
08 Jul 2020 36.660 36.960 36.360 36.960 2,217 -
07 Jul 2020 36.090 36.880 36.000 36.840 4,569 -
06 Jul 2020 36.530 37.050 36.260 37.050 8,591 -
02 Jul 2020 35.400 35.880 35.290 35.855 2,549 -
01 Jul 2020 34.800 35.095 34.410 34.760 13,177 -
30 Jun 2020 34.490 35.000 33.990 35.000 14,565 -
29 Jun 2020 34.450 34.570 32.090 32.090 8,477 -
26 Jun 2020 35.730 35.730 32.200 33.040 20,827 -
25 Jun 2020 35.510 36.270 35.240 36.270 5,533 -
24 Jun 2020 36.410 36.410 36.100 36.100 1,695 -
23 Jun 2020 36.910 37.465 36.630 37.060 5,570 -
22 Jun 2020 36.780 37.165 36.670 37.105 1,855 -
19 Jun 2020 36.830 37.140 36.345 36.345 3,400 -
18 Jun 2020 36.370 37.140 36.370 36.800 19,436 -
17 Jun 2020 38.750 40.780 38.000 40.780 8,889 -
16 Jun 2020 38.910 39.100 38.470 39.100 2,455 -
15 Jun 2020 38.100 39.030 37.930 39.030 7,500 -
12 Jun 2020 37.860 38.230 37.120 37.660 4,816 -
Summary
Current 2 Weeks
(30 Jun 2020 to 14 Jul 2020)
34.490 37.050 33.840 34.500 68,441 -
Previous 2 Weeks
(16 Jun 2020 to 29 Jun 2020)
38.910 39.100 33.840 32.090 78,137 -
4 Weeks from
(18 May 2020 to 15 Jun 2020)
35.440 37.050 33.840 39.030 124,067 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.